Cardiac-specific leptin receptor deletion exacerbates ischaemic heart failure in mice

Cardiovascular Research

Volumn 89, Issue 1, 2011, Pages 60-71

  McGaffin, Kenneth R ^a   Witham, William G ^a   Yester, Keith A ^a   Romano, Lia C ^a   Odoherty, Robert M ^a   McTiernan, Charles F ^a   Odonnell, Christopher P ^a  

^a UNIVERSITY OF PITTSBURGH MEDICAL CENTER   (United States)

Author keywords

Apoptosis; Cre lox; Heart failure; Leptin; Metabolism

Indexed keywords

ADENYLATE KINASE; ADIPOCYTOKINE; CASPASE 3; COLLAGEN; LEPTIN; LEPTIN RECEPTOR; MATRIX METALLOPROTEINASE; OBESITY RELATED ADIPOKINE; STAT3 PROTEIN; TAMOXIFEN; UNCLASSIFIED DRUG;

ANAEROBIC METABOLISM; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CARDITIS; CELL SPECIFICITY; CELL SURVIVAL; CONTROLLED STUDY; DISEASE EXACERBATION; ECHOCARDIOGRAPHY; ENZYME ACTIVATION; ENZYME ACTIVITY; GENE DELETION; GENE INACTIVATION; GENOTYPE; GLYCOLYSIS; HEART DILATATION; HEART EJECTION FRACTION; HEART FAILURE; HEART FUNCTION; HEART HYPERTROPHY; HEART INFARCTION; HEART INFARCTION SIZE; HEART LEFT VENTRICLE ENDDIASTOLIC VOLUME; HEART LEFT VENTRICLE ENDSYSTOLIC VOLUME; HEART MUSCLE CELL; HEART MUSCLE CONTRACTILITY; HEART OUTPUT; HEART PERFUSION; HEART RATE; HEART RIGHT VENTRICLE ENDDIASTOLIC VOLUME; HEART RIGHT VENTRICLE ENDSYSTOLIC VOLUME; HEART STROKE VOLUME; ISCHEMIC HEART DISEASE; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; REAL TIME POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; WESTERN BLOTTING; WILD TYPE; ZYMOGRAPHY;

AMINOIMIDAZOLE CARBOXAMIDE; AMP-ACTIVATED PROTEIN KINASES; ANIMALS; ENZYME ACTIVATION; GLYCOLYSIS; HEART FAILURE; MALE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MODELS, CARDIOVASCULAR; MYOCARDIAL INFARCTION; MYOCARDIAL ISCHEMIA; MYOCYTES, CARDIAC; RIBONUCLEOTIDES; SIGNAL TRANSDUCTION; STAT3 TRANSCRIPTION FACTOR; TAMOXIFEN;

EID: 78650504740     PISSN: 00086363     EISSN: 17553245     Source Type: Journal    
DOI: 10.1093/cvr/cvq288     Document Type: Article

References (40)

1. Shuldiner AR, Yang R, Dong DW. Resistin, obesity, and insulin resistance: the emerging role of the adipoctye as an endocrine organ. N Engl J Med 2001;345:145-146.
2. McGaffin KR, Sun CK, Rager JJ, Romano LC, Zou B, Mathier MA et al. Leptin signalling reduces the severity of cardiac dysfunction and remodelling after chronic ischaemic injury. Cardiovasc Res 2008;77:54-63.
3. McGaffin KR, Moravec CS, McTiernan CF. Leptin signaling in the failing and mechanically unloaded human heart. Circ Heart Fail 2009;2:676-683.
4. Minhas K, Khan SA, Raju SV, Phan AC, Gonzalez DR, Skaf MW et al. Leptin repletion restores depressed {beta}-adrenergic contractility in ob/ob mice independently of cardiac hypertrophy. J Physiol 2005;565:462-474.
5. Barouch LA, Berkowitz DE, Harrison RW, O'Donnell CP, Hare JM. Disruption of leptin signaling contributes to cardiac hypertrophy independently of body weight in mice. Circulation 2003;108:754-759.
6. Barouch LA, Gao D, Lei C, Miller KL, Xu W, Phan AC et al. Cardiac myocyte apop-tosis is associated with increased DNA damage and decreased survival in murine models of obesity. Circ Res 2006;98:119-124.
7. Mazumder PK, O'Neill BT, Roberts MW, Buchanan J, Yun UJ, Cooksey RC et al. Impaired cardiac efficiency and increased fatty acid oxidation in insulin-resistant ob/ ob mouse hearts. Diabetes 2004;53:2366-2374.
8. Panagia M, Schneider JE, Brown B, Cole MA, Clarke K. Abnormal function and glucose metabolism in the type-2 diabetic db/db mouse heart. Can J Physiol Pharmacol 2007;85: 289-294.
9. Meisel SR, Ellis M, Pariente C, Pauzner H, Liebowitz M, David D et al. Serum leptin levels increase following acute myocardial infarction. Cardiology 2001;95:206-211.
10. Schulze PC, Kratzsch J, Linke A, Schoene N, Adams V, Gielen S et al. Elevated serum levels of leptin and soluble receptor in patients with advanced chronic heart failure. Eur J Heart Fail 2003;5:33-40.
11. McGaffin KR, Zou B, McTiernan CF, O'Donnell CP. Leptin attenuates cardiac apop-tosis after chronic ischaemic injury. Cardiovasc Res 2009;83:313-324.
12. Dolinsky V, Dyck JR. Role of AMP-activated protein kinase in healthy and diseased hearts. Am J Physiol Heart Circ Physiol 1006;291:H2557-H2569.
13. Cohen P, Zhao C, Cai X, Montez JM, Rohani SC, Feinstein P et al. Selective deletion of leptin receptor in neurons leads to obesity. J Clin Invest 2001;108:1113-1121.
14. Naghshin J, McGaffin KR, Witham WG, Mathier MA, Romano LC, Smith SH et al. Chronic intermittent hypoxia increases left ventricular contractility in C57BL/6J mice. J Appl Physiol 2009;107:787-793.
15. Lopaschuk GD, Barr RL. Measurements of fatty acid and carbohydrate metabolism in the isolated rat heart. Mol Cell Biochem 1997;172:137-147.
16. Koitabashi N, Bedja D, Zaiman AL, Pinto YM, Zhang M, Gabrielson KL et al. Avoidance of transient cardiomyopathy in cardiomyocyte-targeted tamoxifen-induced Mer-CreMer gene deletion models. Circ Res 2009;105:12-15.
17. Fruhbeck G. Intracellular signaling pathways activated by leptin. Biochem J 2006;393: 7-20.
18. Li H-L, Yin R, Chen D, Liu D, Wang D, Yang Q et al. Long-term activation of adeno-sine monophosphate-activated protein kinase attenuates pressure-overload-induced cardiac hypertrophy. J Cell Biochem 2007;100:1086-1099.
19. Russell RR, Bergerson R, Shulman GI, Young L. Translocation of myocardial glut-4 and increased glucose uptake through activation of AMPK by AICAR. Am J Heart Circ Physiol 1999;277:643-649.
20. Matsui H, Motooka M, Koike H, Inoue M, Iwasaki T, Suzuki T et al. Ischemia/reperfu-sion in rat heart induces leptin and leptin receptor gene expression. Life Sci 2007;80: 672-680.
21. Krishnamurthy P, Rajasingh J, Lambers E, Qin G, Losordo DW, Kishore R. IL-10 inhibits inflammation and attenuates left ventricular remodeling after myocardial infarction via activation of STAT3 and suppression of HuR. Circ Res 2009;104:e9-e18.
22. Hilfiker-Kleiner D, Hilfiker A, Drexler H. Many good reasons to have STAT3 in the heart. Pharmacol Ther 2005;107:131-137.
23. Russell R, Li J, Coven DL, Pypaert M, Zechner C, Palmeri M et al. AMP-activated protein kinase mediates ischemic glucose uptake and prevents postischemic cardiac dysfunction, apoptosis, and injury. J Clin Invest 2004;114:495-503.
24. Greer JJ, Ware DP, Lefer DJ. Myocardial infarction and heart failure in the db/db diabetic mouse. Am J Physiol Heart Circ Physiol 2006;290:H146-H153.
25. Madani S, De Girolamo S, Munoz DM, Li RK, Sweeney G. Direct effects of leptin on size and extracellular matrix components of human pediatric ventricular myocytes. Cardiovasc Res 2006;69:716-725.
26. Rajapurohitam V, Gan XT, Kirshenbaum LA, Karmazyn M. The obesity-associated peptide leptin induces hypertrophy in neonatal rat ventricular myocytes. Circ Res 2003;93:277-279. (Pubitemid 37048239)
27. Xu FP, Chen MS, Wang YZ, Yi Q, Lin SB, Chen AF et al. Leptin induces hypertrophy via endothelin-1-reactive oxygen species pathway in cultured neonatal rat cardiomyo-cytes. Circulation 2004;110:1269-1275.
28. Pinieiro R, Iglesias M, Eiras S, Vinuela J, Lago F, Gonzales-Juanatey JR. Leptin does not induce hypertrophy, cell cycle alterations, or production of MCP-1 in cultured rat and mouse cardiomyocytes. Endocr Res 2005;31:375-386.
29. Iwata M, Cowling RT, Gurantz D, Moore C, Zhang S, Yuan JX et al. Angiotensin-(1-7) binds to specific receptors on cardiac fibroblasts to initiate antifibrotic and antihyper-trophic effects. Am J Physiol Heart Circ Physiol 2005;289:H2356-H2363.
30. Jin H, Li W, Yang R, Ogasawara A, Lu H, Paoni NF. Inhibitory effects of interferon-gamma on myocardial hypertrophy. Cytokine 2005;31:405-414.
31. Hutchinson KR, Stewart JA, Lucchesi PA. Extracellular matrix remodeling during the progression of volume overload-induced heart failure. J Mol Cell Card 2010;48: 564-569.
32. Janicki JS, Brower GL, Gardner JD, Chancey AL, Stewart JA. The dynamic interaction between matrix metalloproteinase activity and adverse myocardial remodeling. Heart Failure Reviews 2004;9:33-42.
33. Tao ZY, Cavasin MA, Yang F, Liu YH, Yang XP. Temporal changes in matrix metallo-proteinase expression and inflammatory response associated with cardiac rupture after myocardial infarction in mice. Life Sci 2004;74:1561-1572.
34. ′- monophosphate-activated protein kinase promotes macrophage polarization to an anti-inflammatory pheno-type. J Immunol 2008;181:8633-8641.
35. Nath N, Giri S, Prasad R, Salem ML, Singh AK, Singh I. 5-Aminoimidazole-4-carboxamide ribonucleoside: a novel immunomodulator with therapeutic efficacy in experimental autoimmune encephalomyelitis. J Immunol 2005;175:566-574.
36. Shin EJ, Schram K, Zheng XL, Sweeny G. Leptin attenuates hypoxia/oxygen-induced activation of the intrinsic pathway of apoptosis in rat H9c2 cells. J Cell Physiol 2009; 221:490-497.
37. Kewalramani G, Puthanveetil P, Wang F, Kim MS, Deppe S, Abrahani A et al. AMP-activated protein kinase confers protection against TNF-alpha-induced cardiac cell death. Cardiovasc Res 2009;84:42-53.
38. Trivedi P, Yang R, Barouch LA. Decreased p110a catalytic activity accompanies increased myocyte apoptosis and cardiac hypertrophy in leptin deficient ob/ob mice. Cell Cycle 2008;7:560-565.
39. Buchanan J, Mazumder PK, Ping H, Chakrabarti G, Roberts MW, Yun UJ et al. Reduced cardiac efficiency and altered substrate metabolism preceded the onset of hyperglycemia and contractile dysfunction in two mouse models of insulin resistance and obesity. Endocrinology 2005;146:5341-5349.
40. Lopaschuk GD, Ussher J, Folmes CD, Jaswal JS, Stanley WC. Myocardial fatty acid metabolism in health and disease. Physiol Rev 2010;90:207-258.